Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
67.8M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
44.6M
-
Shares change
-
-5.31M
-
Total reported value, excl. options
-
$89.6M
-
Value change
-
-$10.3M
-
Number of buys
-
23
-
Number of sells
-
-45
-
Price
-
$2.01
Significant Holders of Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) as of Q3 2025
79 filings reported holding CLYM - Climb Bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Climb Bio, Inc. - Common Stock, par value $0.0001 per share (CLYM) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.6M shares
of 67.8M outstanding shares and own 65.79% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (31.4M shares), VANGUARD GROUP INC (1.32M shares), Affinity Asset Advisors, LLC (1.3M shares), Kynam Capital Management, LP (1.03M shares), TANG CAPITAL MANAGEMENT LLC (1M shares), BlackRock, Inc. (736K shares), Peapod Lane Capital LLC (562K shares), CANTOR FITZGERALD, L. P. (547K shares), RENAISSANCE TECHNOLOGIES LLC (537K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (527K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.